Skip to content
Review Open access

Evolution of Computational Chemistry Applied to Virtual Drug Screening: A Mini-Review

Oct 2026 · Scientific Electronic Archives · 0 citations · 3 references

TL;DR

In conclusion, integrating computational tools, physicochemical criteria, and experimental validation can reduce costs, support decision-making, and increase the efficiency of therapeutic candidate discovery.

Abstract

Computational chemistry has become a strategic component of drug design by enabling the evaluation of large chemical libraries, the investigation of molecular interactions, and the prioritization of candidates before experimental testing. This mini-review examines the evolution of computational chemistry applied to virtual screening, highlighting its main approaches, the physicochemical filters used for compound selection, and the incorporation of artificial intelligence-based methods. A narrative review of the literature was conducted using Scopus, Web of Science, PubMed, SciELO, and ScienceDirect, supplemented by Google Scholar. Publications from 2015 to 2026 were prioritized, along with seminal studies on the Lipinski, Ghose, Egan, Muegge, and Veber filters. The literature indicates that structure-based and ligand-based drug design provide complementary strategies for the identification and optimization of bioactive molecules. Methods such as molecular docking, molecular dynamics, QSAR, pharmacophore modeling, and ADMET prediction improve selection efficiency, whereas descriptors such as molecular weight, lipophilicity, solubility, polar surface area, ionization, flexibility, and the fraction of sp³ carbons (Fsp³) aid in assessing pharmacokinetic potential. Machine learning and deep learning have expanded the ability to explore vast chemical spaces and predict molecular properties. However, the reliability of computational results depends on the quality of the structures, data, and models employed. In conclusion, integrating computational tools, physicochemical criteria, and experimental validation can reduce costs, support decision-making, and increase the efficiency of therapeutic candidate discovery.  

Read PDF

Similar papers

Review Open access Oct 2026

Transforming modern drug discovery with molecular modeling and artificial intelligence

Background: Techniques such as Molecular Modeling and Artificial Intelligence in drug discovery have revolutionized the field by improving target identification, virtual screening, lead optimization, and toxicity prediction. Although many computational techniques exist, the literature offers few systematic, comprehensi...

Nidhi Gairola, Praveen Kumar, Meenu Chaudhary · 0 citations
Review Open access 2026

CADD-Driven Molecular Design: Computational Strategies for the Discovery and Optimization of Bioactive Molecules

This review provides a comprehensive treatment of the theoretical foundations, computational methodologies, and practical applications that define modern CADD, beginning with its historical evolution and foundational concepts-structure-activity relationships, molecular interactions, descriptors, and energy minimization...

Anitha Sadula, Usha Rani Peddaboina, A. P et al. · 1 citation
Review Open access Oct 2026

Medicinal Chemistry in Modern Drug Discovery: Rational Design, Structure–Activity Relationships, And Future Perspectives

Medicinal chemistry is a key field in contemporary drug discovery, bringing together the knowledge and understanding of chemical structures and biological activity, therapeutic efficacy, selectivity, pharmacokinetics and safety. The focus of this review is on rational molecular design, structure–activity relationships...

V. G. Geetha · 0 citations
Review Oct 2026

AlphaFold-driven structure-based drug discovery: Capabilities, benchmarks and limitations for medicinal chemistry.

This review covers the aspects of SBDD approach, traditional methods of protein structure determination and limitations that have restricted the application of this methodology, and addresses the use of AlphaFold models in major drug discovery processes including target identification, binding site prediction, molecula...

M. Pathak · 0 citations

In Silico Drug Design of Chikungunya Antivirals: Using Consensus Methods for Virtual Screening.

This chapter will conduct a virtual screening using AutoDock Vina, AutoDock4, and LeDock, and then combine their results employing the Exponential Consensus Ranking algorithm, to improve the predictive power of virtual screening and increase the probability of identifying true binders.

Leandro Battini · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.